ArticleMolecular therapy oncolytics2021

RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1.

Wei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.